111 related articles for article (PubMed ID: 15026054)
1. Meridianins, a new family of protein kinase inhibitors isolated from the ascidian Aplidium meridianum.
Gompel M; Leost M; De Kier Joffe EB; Puricelli L; Franco LH; Palermo J; Meijer L
Bioorg Med Chem Lett; 2004 Apr; 14(7):1703-7. PubMed ID: 15026054
[TBL] [Abstract][Full Text] [Related]
2. Indole alkaloids from the tunicate Aplidium meridianum.
Franco LH; Joffé EB; Puricelli L; Tatian M; Seldes AM; Palermo JA
J Nat Prod; 1998 Sep; 61(9):1130-2. PubMed ID: 9748381
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activities of aminopyrimidyl-indoles structurally related to meridianins.
Akue-Gedu R; Debiton E; Ferandin Y; Meijer L; Prudhomme M; Anizon F; Moreau P
Bioorg Med Chem; 2009 Jul; 17(13):4420-4. PubMed ID: 19477650
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry detection of minor new meridianins from the Antarctic colonial ascidians Aplidium falklandicum and Aplidium meridianum.
Núñez-Pons L; Nieto RM; Avila C; Jiménez C; Rodríguez J
J Mass Spectrom; 2015 Jan; 50(1):103-11. PubMed ID: 25601681
[TBL] [Abstract][Full Text] [Related]
5. Identification of two meridianins from the crude extract of the tunicate Aplidium meridianum by tandem mass spectrometry.
Seldes AM; Brasco MF; Franco LH; Palermo JA
Nat Prod Res; 2007 May; 21(6):555-63. PubMed ID: 17497427
[TBL] [Abstract][Full Text] [Related]
6. 3-Acyl-2,6-diaminopyridines as cyclin-dependent kinase inhibitors: synthesis and biological evaluation.
Lin R; Lu Y; Wetter SK; Connolly PJ; Turchi IJ; Murray WV; Emanuel SL; Gruninger RH; Fuentes-Pesquera AR; Adams M; Pandey N; Moreno-Mazza S; Middleton SA; Jolliffe LK
Bioorg Med Chem Lett; 2005 May; 15(9):2221-4. PubMed ID: 15837297
[TBL] [Abstract][Full Text] [Related]
7. Meridianins: marine-derived potent kinase inhibitors.
Bharate SB; Yadav RR; Battula S; Vishwakarma RA
Mini Rev Med Chem; 2012 Jun; 12(7):618-31. PubMed ID: 22512550
[TBL] [Abstract][Full Text] [Related]
8. 7-Bromoindirubin-3'-oxime induces caspase-independent cell death.
Ribas J; Bettayeb K; Ferandin Y; Knockaert M; Garrofé-Ochoa X; Totzke F; Schächtele C; Mester J; Polychronopoulos P; Magiatis P; Skaltsounis AL; Boix J; Meijer L
Oncogene; 2006 Oct; 25(47):6304-18. PubMed ID: 16702956
[TBL] [Abstract][Full Text] [Related]
9. Computer-Aided Drug Design Applied to Marine Drug Discovery: Meridianins as Alzheimer's Disease Therapeutic Agents.
Llorach-Pares L; Nonell-Canals A; Sanchez-Martinez M; Avila C
Mar Drugs; 2017 Nov; 15(12):. PubMed ID: 29186912
[TBL] [Abstract][Full Text] [Related]
10. Activation of protein kinase C promotes human cancer cell growth through downregulation of p18(INK4c).
Matsuzaki Y; Takaoka Y; Hitomi T; Nishino H; Sakai T
Oncogene; 2004 Jul; 23(31):5409-14. PubMed ID: 15107819
[TBL] [Abstract][Full Text] [Related]
11. K252a inhibits proliferation of ovarian cancer cells by upregulating p21WAF1.
Takai N; Ueda T; Nishida M; Nasu K; Fukuda J; Miyakawa I
Oncol Rep; 2005 Jul; 14(1):141-3. PubMed ID: 15944781
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2-(pyrimidin-4-yl)indoles.
Franco LH; Palermo JA
Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):975-7. PubMed ID: 12913239
[TBL] [Abstract][Full Text] [Related]
13. Protective role of Bcl-2 on beta-amyloid-induced cell death of differentiated PC12 cells: reduction of NF-kappaB and p38 MAP kinase activation.
Song YS; Park HJ; Kim SY; Lee SH; Yoo HS; Lee HS; Lee MK; Oh KW; Kang SK; Lee SE; Hong JT
Neurosci Res; 2004 May; 49(1):69-80. PubMed ID: 15099705
[TBL] [Abstract][Full Text] [Related]
14. Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation.
DiMauro EF; Newcomb J; Nunes JJ; Bemis JE; Boucher C; Chai L; Chaffee SC; Deak HL; Epstein LF; Faust T; Gallant P; Gore A; Gu Y; Henkle B; Hsieh F; Huang X; Kim JL; Lee JH; Martin MW; McGowan DC; Metz D; Mohn D; Morgenstern KA; Oliveira-dos-Santos A; Patel VF; Powers D; Rose PE; Schneider S; Tomlinson SA; Tudor YY; Turci SM; Welcher AA; Zhao H; Zhu L; Zhu X
J Med Chem; 2008 Mar; 51(6):1681-94. PubMed ID: 18321037
[TBL] [Abstract][Full Text] [Related]
15. In-vitro antiproliferative activities and kinase inhibitory potencies of meridianin derivatives.
Rossignol E; Debiton E; Fabbro D; Moreau P; Prudhomme M; Anizon F
Anticancer Drugs; 2008 Sep; 19(8):789-92. PubMed ID: 18690090
[TBL] [Abstract][Full Text] [Related]
16. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
[TBL] [Abstract][Full Text] [Related]
17. High-throughput screening of kinase inhibitors by multiplex capillary electrophoresis with UV absorption detection.
He Y; Yeung ES
Electrophoresis; 2003 Jan; 24(1-2):101-8. PubMed ID: 12652579
[TBL] [Abstract][Full Text] [Related]
18. Generation of potent and selective kinase inhibitors by combinatorial biosynthesis of glycosylated indolocarbazoles.
Sánchez C; Salas AP; Braña AF; Palomino M; Pineda-Lucena A; Carbajo RJ; Méndez C; Moris F; Salas JA
Chem Commun (Camb); 2009 Jul; (27):4118-20. PubMed ID: 19568652
[TBL] [Abstract][Full Text] [Related]
19. In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models.
Hoeflich KP; O'Brien C; Boyd Z; Cavet G; Guerrero S; Jung K; Januario T; Savage H; Punnoose E; Truong T; Zhou W; Berry L; Murray L; Amler L; Belvin M; Friedman LS; Lackner MR
Clin Cancer Res; 2009 Jul; 15(14):4649-64. PubMed ID: 19567590
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel 5-substituted indirubins as protein kinases inhibitors.
Beauchard A; Ferandin Y; Frère S; Lozach O; Blairvacq M; Meijer L; Thiéry V; Besson T
Bioorg Med Chem; 2006 Sep; 14(18):6434-43. PubMed ID: 16759872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
